Remdesivir in the treatment of covid-19: a propensity score-matched analysis from a public hospital in new york city assessing renal and hepatic safety

HIGHLIGHTS

  • who: Hyomin Lim and collaborators from the Department of Medicine, Jacobi Medical Center, NYC Health + Hospitals, New York, NY, USADepartment of Economics, University of Piraeus, Piraeus, Greece have published the article: Remdesivir in the Treatment of COVID-19: A Propensity Score-Matched Analysis from a Public Hospital in New York City Assessing Renal and Hepatic Safety, in the Journal: (JOURNAL) of 10/03/2021
  • what: The aim of this analysis was to investigate the kidney- and liver-related safety outcomes of patients with COVID-19 treated with remdesivir in a public hospital in the Bronx . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?